|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
21,670,000 |
Market
Cap: |
33.37(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.39 - $4.12 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Aileron Therapeutics is a clinical stage chemoprotection oncology company. ALRN-6924, Co.'s MDM2/MDMX dual inhibitor, is designed to activate p53, which in turn upregulates p21, a known inhibitor of the cell replication cycle. ALRN-6924 is a chemoprotective agent in clinical development to employ a biomarker strategy, in which Co. focuses on treating patients with p53-mutated cancers. Co.'s clinical development program for ALRN-6924 as a selective chemoprotective agent includes: Its completed Phase 1b open-label clinical trial evaluating ALRN-6924 as a chemoprotective agent in patients with p53-mutated small cell lung cancer, undergoing treatment with second-line topotecan.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
400 |
5,701 |
Total Buy Value |
$0 |
$0 |
$898 |
$11,643 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
3 |
Total Shares Sold |
0 |
0 |
0 |
95,059 |
Total Sell Value |
$0 |
$0 |
$0 |
$367,382 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
12 |
End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Windsor James Brian |
President and CEO |
|
2024-12-05 |
4 |
B |
$2.24 |
$898 |
I/I |
400 |
161 |
0.01 |
-27% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-06-17 |
4 |
S |
$3.25 |
$15,298 |
D/D |
(4,707) |
1,746,549 |
|
-16% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-06-14 |
4 |
S |
$3.30 |
$6,270 |
D/D |
(1,900) |
1,751,256 |
|
-16% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-06-12 |
4 |
S |
$3.25 |
$30,362 |
D/D |
(9,342) |
1,753,156 |
|
-13% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-06-11 |
4 |
S |
$3.25 |
$18,744 |
D/D |
(5,752) |
1,762,498 |
|
-11% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-06-10 |
4 |
S |
$3.30 |
$31,604 |
D/D |
(9,577) |
1,768,250 |
|
-14% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-06-07 |
4 |
S |
$3.25 |
$5,664 |
D/D |
(1,740) |
1,777,827 |
|
-11% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-06-06 |
4 |
S |
$3.27 |
$14,104 |
D/D |
(4,284) |
1,779,567 |
|
-12% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-06-05 |
4 |
S |
$3.30 |
$20,760 |
D/D |
(6,291) |
1,783,851 |
|
-12% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-05-01 |
4/A |
S |
$4.10 |
$85,473 |
D/D |
(20,315) |
1,790,142 |
|
- |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-05-01 |
4 |
S |
$4.10 |
$85,473 |
D/D |
(20,315) |
1,779,306 |
|
31% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-04-30 |
4 |
S |
$4.95 |
$448 |
D/D |
(90) |
1,799,621 |
|
40% |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-04-29 |
4 |
S |
$4.92 |
$53,182 |
D/D |
(10,746) |
1,799,711 |
|
44% |
|
Windsor James Brian |
President and COO |
|
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
7,122 |
|
- |
|
University Of Texas/texas Am Investment Managment |
10% Owner |
|
2024-02-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,810,457 |
|
-35% |
|
Windsor James Brian |
President and COO |
|
2023-12-15 |
4 |
B |
$3.37 |
$758 |
I/I |
225 |
225 |
0.01 |
29% |
|
Windsor James Brian |
President and COO |
|
2023-11-20 |
4 |
B |
$1.97 |
$9,987 |
D/D |
5,076 |
5,122 |
0.01 |
220% |
|
Windsor James Brian |
See RemarksOfficer |
|
2023-10-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
46 |
|
349% |
|
Satter Muneer A |
See Remarks |
|
2021-01-08 |
4 |
B |
$1.10 |
$9,900,000 |
I/I |
9,000,000 |
16,609,449 |
2.66 |
- |
|
Ambros Reinhard J. |
Director |
|
2020-06-15 |
4 |
B |
$1.22 |
$7,076 |
D/D |
5,800 |
5,800 |
2.39 |
- |
|
Von Rickenbach Josef H |
Director |
|
2020-06-08 |
4 |
B |
$1.10 |
$249,999 |
D/D |
227,272 |
445,460 |
2.39 |
- |
|
Satter Muneer A |
See Remarks |
|
2020-06-08 |
4 |
B |
$1.10 |
$4,070,000 |
I/I |
3,700,000 |
7,609,449 |
2.25 |
- |
|
Bailey Jeffrey Allen |
Director |
|
2019-11-15 |
4 |
B |
$0.51 |
$19,962 |
D/D |
39,142 |
74,894 |
2.39 |
- |
|
Bailey Jeffrey Allen |
Director |
|
2019-11-14 |
4 |
B |
$0.51 |
$8,088 |
D/D |
15,858 |
35,752 |
2.39 |
- |
|
Bailey Jeffrey Allen |
Director |
|
2019-11-12 |
4 |
B |
$0.53 |
$10,544 |
D/D |
19,894 |
19,894 |
2.39 |
- |
|
114 Records found
|
|
Page 1 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|